Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables Refunds
Ratios

OptimizeRx (OPRX) Receivables - Other (2016 - 2025)

OptimizeRx's Receivables - Other history spans 10 years, with the latest figure at $3.7 million for Q3 2025.

  • For Q3 2025, Receivables - Other fell 37.99% year-over-year to $3.7 million; the TTM value through Sep 2025 reached $3.7 million, down 37.99%, while the annual FY2024 figure was $3.2 million, 46.67% down from the prior year.
  • Receivables - Other for Q3 2025 was $3.7 million at OptimizeRx, up from $3.5 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $6.1 million in Q4 2023 and bottomed at $2.1 million in Q4 2021.
  • The 5-year median for Receivables - Other is $3.7 million (2022), against an average of $4.1 million.
  • The largest annual shift saw Receivables - Other surged 178.77% in 2021 before it plummeted 46.67% in 2024.
  • A 5-year view of Receivables - Other shows it stood at $2.1 million in 2021, then skyrocketed by 69.73% to $3.6 million in 2022, then soared by 69.62% to $6.1 million in 2023, then crashed by 46.67% to $3.2 million in 2024, then grew by 14.84% to $3.7 million in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Receivables - Other are $3.7 million (Q3 2025), $3.5 million (Q2 2025), and $4.2 million (Q1 2025).